ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1019

The Impact of Hip and Knee Osteoarthritis on the Subsequent Risk of Incident Diabetes: A Population-Based Cohort Study

Tetyana Kendzerska1,2,3, Lauren King1, Ruth Croxford2, Ian Stanaitis3, Angela Wall3 and Gillian Hawker1,2,3, 1University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Women's College Research Institute/Women's College Hospital, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Diabetes, longitudinal studies, osteoarthritis and patient outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoarthritis – Clinical Aspects I: Epidemiology and Progression

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Osteoarthritis (OA) and diabetes commonly co-occur. Potential explanations include common risk factors (aging, obesity) and the effects of OA-related functional limitations on diabetes risk factors (e.g., sedentary behavior exacerbates metabolic syndrome). However, whether or not there is a causal relationship between OA and diabetes is unclear. In a large population-based cohort free of diabetes at baseline, we examined the relationship between self-reported hip and knee OA and incident diabetes.

Methods: A population cohort aged ≥55 years was recruited from 1996-98 and followed through provincial health administrative data to 2014. Subjects with baseline diabetes, rheumatic diseases, and medical conditions associated with functional disability were excluded. Age, sex, height, weight, joint complaints and functional limitations were collected. Hip and knee OA were defined as swelling, pain, or stiffness in any joint lasting 6 weeks in the past 3 months and indication on a joint homunculus that a hip or knee was “troublesome”. Comorbidities were defined using validated algorithms for health administrative data. Using Cox-regressions, we examined the relationship of baseline hip/knee OA (0-2 hips; 0-2 knees) with subsequent incident diabetes as defined from health administrative data (sensitivity – 86%, specificity – 97%), incrementally controlling for age, sex, BMI, preexisting hypertension and cardiovascular disease (CVD), income and prior primary care exposure, and finally walking limitation.

Results:  16,362 participants without baseline diabetes were included: median age 68 years, 61% female and median BMI 25.3 kg/m2. 1,637 (10%) individuals met criteria for hip OA, 2,431 (15%) for knee OA, and 3,908 (24%) for walking limitation. Over a median follow-up of 13 years, 3,539 individuals (22%) developed diabetes. Controlling for baseline age, sex, income, BMI, preexisting hypertension and CVD, and prior primary care exposure, a significant dose-response relationship was observed between number of hip/knee joints with OA and incident diabetes: HR for two vs. no OA hips 1.25, 95% CI: 1.08-1.44 (p=0.003); HR for two vs. no OA knees 1.16, 95%CI: 1.04 -1.29 (p=0.008). Further adjustment for walking limitation resulted in attenuation of these relationships, which became non-significant.

Conclusion: In a large population cohort aged ≥55 years free of diabetes at baseline and after controlling for multiple confounders, the presence and burden of hip and knee OA was a significant independent predictor of incident diabetes. This association was explained largely by OA-related walking limitation. Increased attention to management of hip and knee OA with a view to improving mobility has potential to reduce risk of incident diabetes.


Disclosure: T. Kendzerska, None; L. King, None; R. Croxford, None; I. Stanaitis, None; A. Wall, None; G. Hawker, None.

To cite this abstract in AMA style:

Kendzerska T, King L, Croxford R, Stanaitis I, Wall A, Hawker G. The Impact of Hip and Knee Osteoarthritis on the Subsequent Risk of Incident Diabetes: A Population-Based Cohort Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-hip-and-knee-osteoarthritis-on-the-subsequent-risk-of-incident-diabetes-a-population-based-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-hip-and-knee-osteoarthritis-on-the-subsequent-risk-of-incident-diabetes-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology